HuGE Literature Finder
Records
1
-
5
Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension. Molecular and cellular biochemistry 2017 Feb . Imbalzano Egidio, Vatrano Marco, Quartuccio Sebastiano, Di Stefano Rossella, Aragona Caterina Oriana, Mamone Federica, D'Ascola Angela, Scuruchi Michele, Felice Francesca, Trapani Giovanni, Alibrandi Angela, Ciconte Vincenzo Antonio, Ceravolo Roberto, Saitta Antonino, Mandraffino Giusep |
FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants. Nutrition, metabolism, and cardiovascular diseases : NMCD 2015 Sep 25 (9): 875-80. Ibarretxe D, Girona J, Plana N, Cabré A, Heras M, Ferré R, Merino J, Vallvé J C, Masana |
Associations of the eNOS G894T gene polymorphism with target organ damage in children with newly diagnosed primary hypertension. Pediatric nephrology (Berlin, Germany) 2015 Aug . ?ladowska-Koz?owska Joanna, Litwin Mieczys?aw, Niemirska Anna, Wierzbicka Aldona, Roszczynko Marta, Szperl Ma?gorza |
Osteopontin promoter polymorphism is associated with increased carotid intima-media thickness. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2008 Aug 21 (8): 954-60. de las Fuentes Lisa, Gu C Charles, Mathews Santhosh J, Reagan Joann L, Ruthmann Nicholas P, Waggoner Alan D, Lai Chung-Fang, Towler Dwight A, Dávila-Román Víctor |
Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders. Journal of clinical lipidology 0 10 (2): 330-338.e2. Ibarretxe Daiana, Girona Josefa, Amigó Núria, Plana Núria, Ferré Raimón, Guaita Sandra, Mallol Roger, Heras Mercedes, Masana Lu |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: